Literature DB >> 17292532

Dietary zinc and prostate cancer risk: a case-control study from Italy.

Silvano Gallus1, Roberto Foschi, Eva Negri, Renato Talamini, Silvia Franceschi, Maurizio Montella, Valerio Ramazzotti, Alessandra Tavani, Luigino Dal Maso, Carlo La Vecchia.   

Abstract

OBJECTIVES: Zinc concentration is higher in the prostate than in most other tissues. Since information on the role of zinc on prostate carcinogenesis is controversial, we analysed the issue in a case-control study.
METHODS: Between 1991 and 2002, we conducted a multicentre hospital-based case-control study on prostate cancer in Italy. Cases included 1294 men with incident, histologically confirmed prostate cancer. Controls included 1451 patients admitted to the same hospitals as cases for a wide spectrum of acute non-neoplastic, non-hormone-related diseases. Zinc intake was computed from a valid and reproducible food frequency questionnaire, with the use of an Italian food composition database. Odds ratios (OR) of dietary intake of zinc and the corresponding 95% confidence intervals (CI) were estimated by unconditional multiple logistic regression models, after allowance for several covariates, including total energy.
RESULTS: Compared with the lowest quintile, the OR for the highest quintile was 1.56 (95% CI, 1.07-2.26), with a significant trend in risk (p=0.04). The trend in risk was significant for advanced cancers only, the OR being 2.02 (95% CI, 1.14-3.59) for prostate cancers with a high Gleason score.
CONCLUSIONS: In this large study we found a direct association between high zinc intake and prostate cancer risk, particularly for advanced cancers. Our findings allow one to exclude a favourable effect of zinc on prostate carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292532     DOI: 10.1016/j.eururo.2007.01.094

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  21 in total

Review 1.  Zinc and zinc-containing biomolecules in childhood brain tumors.

Authors:  Jan Hrabeta; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Sona Krizkova; Vojtech Adam
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

2.  A Critical Assessment of Epidemiology Studies Regarding Dietary/Supplemental Zinc and Prostate Cancer Risk.

Authors:  Leslie C Costello; Renty B Franklin; Ming T Tan
Journal:  Open Urol Nephrol J       Date:  2008

Review 3.  Metabolic targets for potential prostate cancer therapeutics.

Authors:  Jeffrey Twum-Ampofo; De-Xue Fu; Antonino Passaniti; Arif Hussain; M Minhaj Siddiqui
Journal:  Curr Opin Oncol       Date:  2016-05       Impact factor: 3.645

4.  Resveratrol-zinc combination for prostate cancer management.

Authors:  Chandra K Singh; Anna Pitschmann; Nihal Ahmad
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

5.  Zinc intake from supplements and diet and prostate cancer.

Authors:  Alejandro Gonzalez; Ulrike Peters; Johanna W Lampe; Emily White
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

6.  High-dose dietary zinc promotes prostate intraepithelial neoplasia in a murine tumor induction model.

Authors:  Young Hwii Ko; Yu Jeong Woo; Jin Wook Kim; Hoon Choi; Seok Ho Kang; Jeong Gu Lee; Je Jong Kim; Hong Seok Park; Jun Cheon
Journal:  Asian J Androl       Date:  2009-12-14       Impact factor: 3.285

Review 7.  Zinc and zinc transporters in prostate carcinogenesis.

Authors:  Vladimir Kolenko; Ervin Teper; Alexander Kutikov; Robert Uzzo
Journal:  Nat Rev Urol       Date:  2013-03-12       Impact factor: 14.432

8.  Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study.

Authors:  Yuqing Zhang; Patricia Coogan; Julie R Palmer; Brian L Strom; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2008-12-18       Impact factor: 2.506

Review 9.  Dietary factors and risk for advanced prostate cancer.

Authors:  Wambui G Gathirua-Mwangi; Jianjun Zhang
Journal:  Eur J Cancer Prev       Date:  2014-03       Impact factor: 2.497

10.  Direct intra-tumoral injection of zinc-acetate halts tumor growth in a xenograft model of prostate cancer.

Authors:  Maulik R Shah; Christopher L Kriedt; Nathan H Lents; Mary K Hoyer; Nimah Jamaluddin; Claudette Klein; Joseph Baldassare
Journal:  J Exp Clin Cancer Res       Date:  2009-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.